1 Nothing is more difficult to undertake, more perilous to conduct or more uncertain in its outcome, than to take the lead in introducing a new order of.

Slides:



Advertisements
Similar presentations
Unique Device Identification (UDI) System for Medical Devices Dr Larry Kelly Therapeutic Goods Administration.
Advertisements

Unique Device Identification
Unique Device Identifier (UDI) - Overview 6/21/2014
ILISA B.G. BERNSTEIN, PHARM.D., J.D. U.S. Food and Drug Administration
Unique Device Identification and HL7 Messages HL7 Working Groups 27 th Annual Plenary Meeting September 2013 Terrie Reed, Associate Director, Informatics.
“Paperless Labeling Rule” Proposed Rule First Look January 2015.
Options for Regulation and the Impact of Regulation on the Marketplace 29 November 2005 Alan Kent
UDI and the GMDN (Global Medical Device Nomenclature)
GS1 Healthcare Roadmap January 2015.
Medical Devices Approval Process
Cross-Labeling: Legal and Regulatory Issues David M. Fox Hogan & Hartson LLP th Street, NW Washington, DC
Pre-Market and the QSR Presented by: Dawn Fernandes.
CDRH Software Regulation
External Defibrillators: Recalls, Inspections, and the Quality System Regulation Melissa Torres Office of Compliance December 15, 2010.
The FDA Landscape AdvaMed September 2008 Judith K. Meritz
Unique Device Identification and Global Medical Device Nomenclature Jay Crowley Senior Advisor for Patient Safety Food and Drug Administration
1 Unique Device Identification (UDI) – Enabling the Transformation of Medical Device Safety Terrie Reed, MSIE Associate Director, Informatics
Unique Device Identification Jay Crowley Senior Advisor for Patient Safety Food and Drug Administration
Unique Device Identification (UDI): Implementation and Adoption Leslie M Tompkins, PhD FDA, Center for Devices and Radiological Health UDI Lead, Standards.
Classification of HLA Devices FDA Introduction & Background Sheryl A. Kochman CBER/OBRR/DBA.
Overview of Medical Devices Sector Saudi Food and Drug Authority (Saudi Arabia) Dr. Saleh Al Tayyar Director General Medical Devices Sector Saudi Food.
Office of Combination Products: Current Initiatives
DRAFT Guidance for Industry: Providing Regulatory Submissions in Electronic Format – Drug Establishment Registration and Drug Listing Denise Sánchez, J.D.,
Software as a Medical Device (SaMD) Application of Quality Management System IMDRF/WG/N23 Proposed Document (PD1)R3.
Regulatory Update Ellen Leinfuss SVP, Life Sciences.
UDI: From Regulation to Value
Regulatory Affairs Domain
Prof. Moustafa M. Mohamed Vice dean Faculty of Allied Medical Science Pharos University in Alexandria Development and Regulation of Medical Products (MEDR-101)
Work product for review and discussion by the FDASIA Regulation Subgroup; May not reflect the subgroup’s views REGULATORY WEAKNESSES A report of the typist.
GS1 US INITIATIVES UPDATE MARCH 18, GS1 STANDARDS MAKES IT POSSIBLE 2 SAFETYSECURITY VISIBILITYEFFICIENCY COLLABORATION To apply standards to business.
Regulatory Primer 101 Patrick Kennelly, Chief Food Safety Section California Department of Public Health March 11, 2014.
1 CONSENSUS STANDARDS OIVD WORKSHOP April 22-23, 2003 Rockville MD Ginette Y. Michaud, M.D. OIVD.
© Siemens AG 2014 Alle Rechte vorbehalten.siemens.com/lowvoltage New Legislative Framework (NLF) Sektor Infrastructure & Cities | Division Low and Medium.
Preventive Controls for Human Food S upplemental Proposal 1
Final Rule for Preventive Controls for Human Food September 16, THE FUTURE IS NOW 1.
FDLI Introduction to Medical Device Law and Regulation Other Postmarket Controls Philip Katz (202) October 29, 2002 Washington,
Introduction to the ISBT 128 Labelling Standard for Blood Components.
1 In attempting to arrive at the truth, I have applied everywhere for information, but in scarcely an instance have I been able to obtain hospital records.
Barcode Technology in healthcare Nowadays, published reports illustrate high rates of medical error (adverse events) and the increasing costs of healthcare.
Utah Life Science Summit Nov Phil Triolo, PhD RAC President, Phil Triolo and Associates LC.
1 October, 2015 HL 7 Working Group Meeting. FDA UDI Rule – 9/24/2013 Unique device identifier (UDI) means an identifier that adequately identifies a device.
UPCOMING CHANGES TO IN-VITRO DIAGNOSTICS (IVDs) AND LABORATORY DEVELOPED TESTS (LDTs) REGULATIONS Moj Eram, PhD November 5, 2015.
Investigational Devices and Humanitarian Use Devices June 2007.
Final Rule for Preventive Controls for Animal Food 1 THE FUTURE IS NOW.
1 October, 2015 HL 7 Working Group Meeting. FDA UDI Rule – 9/24/2013 Unique device identifier (UDI) means an identifier that adequately identifies a device.
Uniformal barcode processing for patient safety and efficiency Brief Proposal Esther Peelen, GS1 en Erik Zwarter, ErasmusMC 19 October 2015.
GS1 DataMatrix Instructions
When Supply Chain meets Care Delivery: Background on GS1 and HL7 Ulrike Kreysa Director Healthcare, GS1 Global Office.
AMERICAS | ASIA PACIFIC | EMEA Medical Devices: Concept to Commercialization How to avoid delays in getting your product cleared/approved by FDA Robert.
Workshop on Accreditation of Bodies Certifying Medical Devices Kiev, November 2014.
NOTE: To change the image on this slide, select the picture and delete it. Then click the Pictures icon in the placeholder to insert your own image. National.
GS1 DataMatrix Instructions
ISO/IEEE Support for UDI
Unique Device Identification Update – FDA and GHTF
Final Rule for Preventive Controls for Human Food
U.S. FDA Center for Devices and Radiological Health Update
Premarket Notification 510(k) process
FDA’s IDE Decisions and Communications
FDA-CDRH in the Next Decade A Vision for Change
Regulatory and Standards Work Group Presentation On UDI/UDID
Proposal for a Regulation on medical devices and Proposal for a Regulation on in vitro diagnostic medical devices Key Provisions and GIRP Assessment.
HL7 International January Working Group Meeting Health Care Device WG
Combination products The paradigm shift
Plastic Pipe Rule – Tracking and Traceability Proposed Requirements
NEW MDR Regulatory Context. NEW MDR Regulatory Context.
What Is VQIP? FDA required to establish a program to provide for the expedited review of food imported by voluntary participants. Eligibility is limited.
Global Medical Device Nomenclature (GMDN)
Towards International Harmonized Nomenclature for Medical Devices
Final Rule on Foreign Supplier Verification Programs
Implementation of FDASIA: Unique Device Identifiers (UDI)
Presentation transcript:

1 Nothing is more difficult to undertake, more perilous to conduct or more uncertain in its outcome, than to take the lead in introducing a new order of things. For the innovator has for enemies all those who have done well under the old and lukewarm defenders amongst those who may do well under the new. Niccolo Machiavelli (1523)

2 Unique Device Identification (UDI) – Transforming the Global Medical Device Landscape Jay Crowley Senior Advisor for Patient Safety Food and Drug Administration

3 3 History of FDA’s UDI Project 1999 IOM Report – To Err is Human 2004 FDA Pharmaceutical Barcode Rule 2005 and 2006 FDA/FDLI Meeting on UDI 2006 Public Meeting and Docket FDA-2006N FDA Amendments Act of – UDI Database Pilots 2008 GHTF Ad-Hoc Working Group on UDI 2009 UDI Workshop and Docket FDA-2008-N September – GHTF UDI Guidance published 2012 July 10 th – UDI Proposed Regulation Publishes 2012 FDASIA provisions added 2012 November 7 th – comment period closes 2012 November 19 th – FDASIA amendment (Dec 19) 2013 May – draft GUDID User’s Guide (guidance) 2013 June – UDI Final Rule

4 44 Legislation (FDAAA 07; FDASIA 12) Not later than December 31, 2012, the Secretary shall issue proposed regulations establishing a unique device identification system for medical devices requiring the label of devices to bear a unique identifier, unless the Secretary requires an alternative placement or provides an exception for a particular device or type of device. The unique identifier shall adequately identify the device through distribution and use, and may include information on the lot or serial number. The Secretary shall finalize the proposed regulations not later than 6 months after the close of the comment period and shall implement the final regulations with respect to devices that are implantable, life-saving, and life sustaining not later than 2 years after the regulations are finalized, taking into account patient access to medical devices and therapies.

5 Public Health Benefits UDID provides global visibility and supports: Medical device recalls Adverse event reporting Tracking and tracing Supply chain security Anti-counterfeiting/diversion Disaster/terror preparation Shortages/substitutions Reduction of medical errors (e.g., bedside scanning) An easily accessible source of device information for patients and clinicians

6 Clinical Impact of UDIs Scanning devices at facility entry and maintaining UDI in the hospital information system would provide traceability (e.g., recalls) Scanning the device when it is used in a patient would provide documentation of use (EHRs/PHRs) Bedside scanning for device verification – e.g., latex allergy, MRI compatibility, recalled devices UDI Database provides national catalogue of ALL devices – find appropriate device, find comparable devices in cases of disaster or shortages/substitutions

7 7 GHTF/IMDRF UDI AHWG Formed October 2008; EC Chair (Laurent Selles) Members US (FDA, AdvaMed), Europe (EC, Eucomed, EDMA), Japan, Canada – and AHWP Guidance published September framework for any regulatory who wants to develop a UDI System Now morphed into IMDRF – work to continue Update to Guidance – addressing issues raised in FDA proposed rule and application to specific device issues – available for review until 31 July 2013 at:

8 UDI Proposed Regulations Original Proposed Rule (July 10, 2012) Changes and additions to Part 801 Labeling New Part 830 – UDI Requirements Conforming Amendments Amendment to proposed rule (November 19, 2012) FDASIA implementation timeframe

9 9 Date Format If label includes a date (expiration, manufacture): Presented as Month Day, Year (JAN 1, 2012) All dates must include a day (JAN 2012 not allowed) The month shown as a three letter abbreviation in capital letters: e.g., JAN, FEB, MAR Day is an number from 1-31 Year is a 4 digit number Effective 1 year after final rule publication

10 Definitions 1.Issuing agency – an organization accredited by FDA to operate a system for the issuance of UDI 2.Labeler – one who applies or modifies the label with intent to put device into interstate commerce w/out any modifications Except the addition of name, contact, etc for a distributor w/out making any other changes

11 Establishing a UDI System Combination of 4 distinct steps: 1.Develop a standardized system to develop the unique device identifiers (UDI) 2.Place the UDI in human readable and/or AutoID on a device, its label, or both 3.Create and maintain the UDI Database 4.Adoption and Implementation

12 1 st – Developing the UDI FDA will accredit issuing agencies (ISO 15459) – e.g., GS1, HIBCC, ICCBBA Develop UDI code according to one of the standards Created and maintained by the manufacturer Concatenating Device and Production Identifier Device Identifier (DI): [static] Manufacturer, make, model [i.e., each catalogue number] Production Identifier (PI): [dynamic] however product is currently controlled – serial, lot number; expiration, manufacturing date

13 2 nd – UDI Application Unique UDI applied to “base package” AND higher levels of packaging Default location is the label Human readable and encoded in a form of automatic identification technology No specific technology (technology neutral) ALSO Direct Part Marking (DPM) for an implantable device (>30 days) intended to be used more than once, and intended to be sterilized before each use stand-alone software

14 General Exemptions Class I Devices do not need to include Production Identifiers in UDI. Devices, other than prescription devices, made available for purchase at a retail establishments, (aka OTC devices, regardless of where distributed). GMP-exempt Class I devices Individual class I, single-use devices, all of a single version or model, that are distributed together in a single device package, which are not intended for individual sale – the UDI is on the package And others…

15 UDI Application Example

16 UDI Application Example

17 UDI Application Example

18 UDI Application Example

19 ISBT128 Device Identifier (Static): A9997T9017Z012 A9997 is the processor identifier assigned by ICCBBA ≡ manufacturer identifier T9017Z012 is the product identifier ≡ catalogue number Production Identifier: A A is the donation identification number ≡ Lot no. 102 is the division number ≡ serial number

20 Combination Products and Kits Combination product (PMOA is a device) has its own UDI; each device constituent needs its own UDI. Except a CP that is physically, chemically, or otherwise combined with other parts of the CP such that it is not possible for the device constituent to be used except as part the CP. Each kit (devices only) has its own UDI; each device packaged in a convenience kit shall have its own UDI, distinct from the kits. Except – a device is intended for a single use does not need its own UDI

21 Global UDI Database For each Device Identifier: Manufacturer (DUNS), Make/model, Brand/Trade Device version/mode/catalogue/reference numbers Clinically relevant size Contact information Sterility information; Contains latex; Single-use Controlled by – Lot and/or Serial Number; Exp. Date FDA premarket authorization (510k, PMA); listing # GMDN PT; FDA product code (procode) Marketing Status/date Higher levels packaging Kit; combination product; Rx/OTC; HCT/P

22 FDA’s Global UDI Database Distribution Web based tool Business Rules Manufacturer (Acme) 3 rd Parties (GDSN) The label of Medical Device 123 Size 45: Device Identifier (Device XYZ123) Production Identifier (Lot #ABC) Expiration date (MMDDYYYY) Sterile; Latex free Bulk HL7 SPL Minimum Data Set For each Device Identifier: Manufacturer and model GMDN Code Other attributes or FDA’s UDI Database FDA FDA Managed Public User Interface

23 GUDID Draft “User’s Guide” Publish draft “user’s guide” in June Explain how interaction with the database will work: Organizational module (DUNS structure, DUNS – match label, various user roles) Device Identifier module/life-cycle, published records, grace period Both web-base (UI) and HL7 SPL Search Comments welcome Future training and database access

24 4 th – Implementation Based on premarket risk class after publication of final rule: class III – 1 year class II implants and life-supporting/life-sustaining devices – 2 years the rest of class II – 3 years class I – 5 years Phase out national numbering system (NDC/NHRIC) Direct part marking requirements are effective 2 years after class effective date (except FDASIA)

25 Request for Exceptions Written requests for exceptions or alternate placement: Identify the device List the provisions for an exception or alternative If an exception, explain why the requirements are not technologically feasible If an alternative - describe the alternative and: -why it would provide better device identification than the original requirements – OR -How the alternative would better ensure the safety or effectiveness of the device

26 Conforming Amendments Part 803 – Medical Device Reporting Part 806 – Reports of Corrections And Removals Part 810 – Medical Device Recall Authority Part 814 – Premarket Approvals Part 820 – Quality System Regulation Part 821 – Medical Device Tracking Requirements Part 822 – Postmarket Surveillance

27 What we have heard… Comments at Docket No. FDA-2011-N-0090 and/or RIN No AG3 - Date format – ISO 8601 (YYYY-MM-DD) and implementation with UDI Existing inventory (stock, consignment) – some sort of extension/exception DPM – issues with implants OTC/retail exemption – likely not as written – instead UPC be UDI for class I devices sold at retail Kits/combinations products – and combo kits Changes requiring a new DI – no tie to premarket

28 UDI MDEpiNet activities Develop roadmap on adoption and implementation of UDIs Develop clinically significant attributes for coronary stents and implement UDI based surveillance activities Develop clinically significant attributes for orthopedic devices Implement UDI based surveillance activities within the International Consortium of Orthopedic Registries (ICOR) ASTER-D - Incorporate UDI into Point-of-Care spontaneous electronic Adverse Event (AE) reporting

29 UDI MDEpiNet activities

30 Strengthening Our National System For Medical Device Postmarket Surveillance

31 Unique Device Identification